pc12 neuronal cell lines (ATCC)
Structured Review
Pc12 Neuronal Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 4408 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pc12+neuronal+cell+lines/PC-12/pm41462282-51-4-12
Average 98 stars, based on 4408 article reviews
Images
Related Articles
Sulforhodamine B Assay:Article Title: Shikonin alleviates rotenone-induced Parkinson's disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production. Article Snippet: The BV2 microglial and Article Title: Shikonin alleviates rotenone-induced Parkinson’s disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production Article Snippet: The BV2 microglial and Western Blot:Article Title: Shikonin alleviates rotenone-induced Parkinson's disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production. Article Snippet: The BV2 microglial and Article Title: Shikonin alleviates rotenone-induced Parkinson’s disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production Article Snippet: The BV2 microglial and Marker:Article Title: Shikonin alleviates rotenone-induced Parkinson's disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production. Article Snippet: The BV2 microglial and Article Title: Shikonin alleviates rotenone-induced Parkinson’s disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production Article Snippet: The BV2 microglial and Control:Article Title: Shikonin alleviates rotenone-induced Parkinson's disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production. Article Snippet: The BV2 microglial and Article Title: Shikonin alleviates rotenone-induced Parkinson’s disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production Article Snippet: The BV2 microglial and Expressing:Article Title: Shikonin alleviates rotenone-induced Parkinson's disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production. Article Snippet: The BV2 microglial and Article Title: Shikonin alleviates rotenone-induced Parkinson’s disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production Article Snippet: The BV2 microglial and TUNEL Assay:Article Title: Shikonin alleviates rotenone-induced Parkinson's disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production. Article Snippet: The BV2 microglial and Article Title: Shikonin alleviates rotenone-induced Parkinson’s disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production Article Snippet: The BV2 microglial and Staining:Article Title: Shikonin alleviates rotenone-induced Parkinson's disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production. Article Snippet: The BV2 microglial and Article Title: Shikonin alleviates rotenone-induced Parkinson’s disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production Article Snippet: The BV2 microglial and Flow Cytometry:Article Title: Shikonin alleviates rotenone-induced Parkinson's disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production. Article Snippet: The BV2 microglial and Article Title: Shikonin alleviates rotenone-induced Parkinson’s disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production Article Snippet: The BV2 microglial and |
